Spain vs World: Access to anti-retroviral drugs, male
Spain
91.0%
in 2022
World
73.0%
in 2024
Spain rank
12th
World rank
15th
Access to anti-retroviral drugs, male over time
- Spain
- World
How they compare
Spain currently reports 91.0% against 73.0% in World, a difference of 18.0%.
That makes Spain's figure about 1.2 times World's.
Across all 23 years both countries report, Spain has been ahead every year.
Spain ranks 12th and World ranks 15th of 141 countries.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Spain | World | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.7% | 7.1% | 34.6% | Spain |
| 2010s | 73.4% | 40.6% | 32.8% | Spain |
| 2020s | 88.7% | 65.0% | 23.7% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Spain or World?
- Spain, at 91.0% against 73.0% in World as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Spain and World?
- 18.0%, with Spain ahead.
- How many years of comparable data are there for Spain and World?
- 23 years are reported by both, from 2000 to 2022.
- How do Spain and World rank globally for access to anti-retroviral drugs, male?
- Spain ranks 12th and World ranks 15th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.